ESCRS has published a new Eurotimes video featuring cornea and refractive surgery specialist, Dr. José Güell. In this ten-minute installment of “Eye Contact,” Dr. Güell discusses how his pre-surgical workup helps to identify potential Meibomian gland dysfunction and other ocular surface disease.
Because anatomical testing and subjective patient reporting alone do not provide enough information, Dr. Güell prefers to objectively assess a patient’s functional limitations prior to multi-focal IOL, laser corneal and other surgical procedures. “From a practical point of view, for me, the best is to evaluate all my refractive patients pre-operatively with the HD Analyzer,“ he explained.
In particular, he finds the Tear Film Analysis to be a valuable test as it evaluates the patient’s optical quality during blinks, and is more indicative of the patient’s everyday experience. If ocular surface dysfunction is present, the underlying cause can be further investigated and treated. A patient can then be re-examined with the HD Analyzer to confirm improvement in the ocular surface before proceeding with surgery. The system’s Ocular Surface Index (OSI) provides an objective data point for comparison before and after treatment.
Watch video below, or at http://player.escrs.org/eurotimes-eye-contact/ocular-surface-disease-jose-guell for Dr. Dr. Güell’s thoughts on why assessment of ocular surface health is so important to successful patient outcomes.
About the Dr.
Dr. José L. Güell is a founding partner of Instituto Microcirugía Ocular of Barcelona and director of the Cornea and Refractive Surgery Department. He is past president of EuCornea and a past president of the European Society of Cataract and Refractive Surgeons. He is also associate professor of ophthalmology at the Universitat Autònoma of Barcelona and scientific coordinator and professor of the anterior segment activities at the European School for Advanced Studies in Ophthalmology (ESASO), USI, in Lugano. Presently, his main areas of interest and research are laser refractive surgery, phakic IOLs, cataract surgery, endothelial transplantation, and corneal surgery.